Weng, Desheng
210  results:
Search for persons X
?
2

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (ant..:

Pan, Qiu-Zhong ; Zhao, Jing-Jing ; Liu, Liang...
Signal Transduction and Targeted Therapy.  9 (2024)  1 - p. , 2024
 
?
3

EBV promotes TCR-T-cell therapy resistance by inducing CD16..:

Chen, Yuanyuan ; Ouyang, Dijun ; Wang, Yan...
Journal for ImmunoTherapy of Cancer.  12 (2024)  6 - p. e008375 , 2024
 
?
4

Surufatinib plus toripalimab in patients with advanced neur..:

Zhang, Panpan ; Shi, Si ; Xu, Jianming...
European Journal of Cancer.  199 (2024)  - p. 113539 , 2024
 
?
10

Correction: Acylglycerol kinase promotes tumour growth and ..:

Zhu, Qian ; Zhong, Ai-Lin ; Hu, Hao...
Journal of Hematology & Oncology.  16 (2023)  1 - p. , 2023
 
?
12

OTUD4-mediated GSDME deubiquitination enhances radiosensiti..:

Di, Muping ; Miao, Jingjing ; Pan, Qiuzhong...
Journal of Experimental & Clinical Cancer Research.  41 (2022)  1 - p. , 2022
 
?
13

SPC25 promotes proliferation and stemness of hepatocellular..:

Yang, Jieying ; Huang, Yue ; Song, Mengjia...
International Journal of Biological Sciences.  18 (2022)  14 - p. 5241-5259 , 2022
 
?
14

Phase I study of pegylated liposomal doxorubicin and cispla..:

Wen, Xi-zhi ; Pan, Qiu-zhong ; Xu, Bu-shu...
Cancer Chemotherapy and Pharmacology.  89 (2022)  2 - p. 209-215 , 2022
 
?
15

CircITGB6 promotes ovarian cancer cisplatin resistance by r..:

Li, Han ; Luo, Fan ; Jiang, Xingyu...
Journal for ImmunoTherapy of Cancer.  10 (2022)  3 - p. e004029 , 2022
 
1-15